Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices

Citation
Mjb. Wissink et al., Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices, J CONTR REL, 64(1-3), 2000, pp. 103-114
Citations number
54
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF CONTROLLED RELEASE
ISSN journal
01683659 → ACNP
Volume
64
Issue
1-3
Year of publication
2000
Pages
103 - 114
Database
ISI
SICI code
0168-3659(20000214)64:1-3<103:IEOVGB>2.0.ZU;2-F
Abstract
Endothelial cell seeding, a promising method to improve the performance of small-diameter vascular grafts, requires a suitable substrate, e.g. crossli nked collagen. In addition, the growth of seeded endothelial cells can be i mproved by local release of a heparin-binding protein, basic fibroblast gro wth factor (bFGF). In this study, the influence of immobilization of hepari n to collagen, crosslinked using N-(3-dimethylaminopropyl)-N'-ethylcarbodii mide (EDC) in combination with N-hydroxysuccinimide (NHS), on the binding a nd release of bFGF was determined. Heparin was immobilized also using EDC a nd NHS. Furthermore, the effects of the release of bFGF from (heparinized) EDC/NHS-crosslinked collagen on the proliferation of seeded endothelial cel ls was studied in vitro. Immobilization of increasing amounts of heparin to EDC/NHS-crosslinked collagen (containing 14 free epsilon-amino groups per 1000 amino acid residues, E/N14C) resulted in binding of increasing amounts of bFGF to the material. Maximal bFGF binding was observed for E/N14C cont aining 20-30 mg heparin immobilized per gram of collagen which was obtained using a molar ratio of EDC to heparin-carboxylic acid groups of 0.4 for he parin immobilization (E/N14C-H(0.4)). Up to concentrations of 320 ng bFGF/m l, 10% of the added bFGF bound to E/N14C, while binding of bFGF to E/N14C-H (0.4) was 22%. The initial release rate of bFGF bound to E/N14C was much hi gher compared to bFGF bound to E/N14C-H(0.4): respectively, 30 vs. 2% in th e first 6 h. After 10 days, the bFGF release from E/N14C and E/N14C-H(0.4) amounted to 83 vs. 42%, respectively. Binding of increasing amounts of bFGF resulted in increased growth of human umbilical vein endothelial cells (HU VECs) seeded on both E/N14C and E/N14C-H(0.4). Nevertheless, after 6 and 10 days of proliferation cell numbers on E/N14C-H(0.4) where higher than cell numbers on E/N14C, irrespective of the bFGF concentration used for loading of the matrix. It is concluded that heparinized, EDC/NHS-crosslinked colla gen is a good synthetic vascular graft coating for in vivo endothelial cell seeding. (C) 2000 Elsevier Science B.V. All rights reserved.